MedPath

Nutrition for Brain and Body Health (BB-Health) Feasibility Trial

Not Applicable
Recruiting
Conditions
Cognition
Obesity
Interventions
Other: Multicomponent nutrition supplement (MCNS)
Behavioral: Behavioral weight loss program
Registration Number
NCT05542199
Lead Sponsor
Tufts University
Brief Summary

The goal of the trial is to determine the feasibility of implementing a specific nutrition regimen used alone or in combination with a behavioral weight loss (WL) intervention on cognition and cerebral blood flow in older adults at risk of cognitive decline.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
48
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
+MCNS+WLBehavioral weight loss programThis group receives the multicomponent nutrition supplement and the behavioral weight loss intervention.
-MCNS+WLBehavioral weight loss programThis group receives the placebo nutrition supplement and the behavioral weight loss intervention.
+MCNS-WLMulticomponent nutrition supplement (MCNS)This group receives the multicomponent nutrition supplement and is in the control group for the behavioral weight loss intervention (no behavioral intervention during the trial, but participant is wait-listed to receive one after the trial finishes).
+MCNS+WLMulticomponent nutrition supplement (MCNS)This group receives the multicomponent nutrition supplement and the behavioral weight loss intervention.
Primary Outcome Measures
NameTimeMethod
Cognitive functionMeasure at baseline (pre-randomization), and 3, 6 and 12 months after randomization

Change in age-sensitive cognitive composite z-score from baseline, based on well-established standardized scores on 5 neuropsychological tests (Controlled Oral; Word Association Test, Digit Symbol Substitution Test; Stroop Interference Test; Trails Making Tests A and B)

Secondary Outcome Measures
NameTimeMethod
Microvascular cerebral blood flow in fasting stateMeasure at baseline (pre-randomization), and 3, 6 and 12 months after randomization

Change in microvascular cerebral blood flow from baseline, measured with diffuse correlation spectroscopy / near infrared spectroscopy during fasting state

Microvascular cerebral blood flow in fed stateMeasure at baseline (pre-randomization), and 3, 6 and 12 months after randomization

Change in microvascular cerebral blood flow from baseline, measured with diffuse correlation spectroscopy / near infrared spectroscopy during fed state

Macrovascular cerebral blood flow velocity in fed stateMeasure at baseline (pre-randomization), and 3, 6 and 12 months after randomization

Change in macrovascular cerebral blood flow velocity measured with transcranial Doppler ultrasound measured during fed state

Macrovascular cerebral blood flow velocity in fasting stateMeasure at baseline (pre-randomization), and 3, 6 and 12 months after randomization

Change in macrovascular cerebral blood flow velocity measured with transcranial Doppler ultrasound measured during fasting state

Trial Locations

Locations (1)

Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath